25 XP   0   0   10

Cisen Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Cisen Pharmaceutical Co Ltd together

PenkeI guess you are interested in Cisen Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cisen Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cisen Pharmaceutical Co Ltd

I send you an email if I find something interesting about Cisen Pharmaceutical Co Ltd.

Quick analysis of Cisen Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Cisen Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥11.81
Expected worth in 1 year
¥14.47
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.88
Return On Investment
26.3%

For what price can you sell your share?

Current Price per Share
¥14.77
Expected price per share
¥13.80 - ¥16.55
How sure are you?
50%

1. Valuation of Cisen Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥14.77

Intrinsic Value Per Share

¥-0.17 - ¥8.85

Total Value Per Share

¥11.64 - ¥20.66

2. Growth of Cisen Pharmaceutical Co Ltd (5 min.)




Is Cisen Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$740.1m$698.6m$41.4m5.6%

How much money is Cisen Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$48.3m$46.1m$2.2m4.5%
Net Profit Margin8.6%8.8%--

How much money comes from the company's main activities?

3. Financial Health of Cisen Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Cisen Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Cisen Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Cisen Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Cisen Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Cisen Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Cisen Pharmaceutical Co Ltd is ¥14.77. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cisen Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cisen Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥11.81. Based on the TTM, the Book Value Change Per Share is ¥0.66 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.56 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cisen Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.110.7%0.110.7%0.100.7%0.130.9%0.090.6%
Usd Book Value Change Per Share0.090.6%0.090.6%0.080.5%0.100.7%0.110.8%
Usd Dividend Per Share0.040.3%0.040.3%0.040.3%0.050.3%0.030.2%
Usd Total Gains Per Share0.130.9%0.130.9%0.120.8%0.151.0%0.151.0%
Usd Price Per Share1.74-1.74-1.84-1.98-1.26-
Price to Earnings Ratio16.32-16.32-18.11-15.41-10.15-
Price-to-Total Gains Ratio12.98-12.98-15.38-13.69-12.42-
Price to Book Ratio1.07-1.07-1.20-1.37-0.93-
Price-to-Total Gains Ratio12.98-12.98-15.38-13.69-12.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.041214
Number of shares489
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.05
Usd Book Value Change Per Share0.090.10
Usd Total Gains Per Share0.130.15
Gains per Quarter (489 shares)65.6071.01
Gains per Year (489 shares)262.39284.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18317925289195274
2166358514179389558
3250538776268584842
433371710383587781126
541689613004479731410
64991075156253611681694
75821254182462613621978
86661433208671515572262
97491613234880517522546
108321792261089419462830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%8.00.04.066.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Cisen Pharmaceutical Co Ltd

About Cisen Pharmaceutical Co Ltd

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Jining, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-18 12:32:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Cisen Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cisen Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.6% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is 8.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY8.8%-0.2%
TTM8.6%5Y11.0%-2.4%
5Y11.0%10Y7.7%+3.3%
1.1.2. Return on Assets

Shows how efficient Cisen Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.1% Return on Assets means that Cisen Pharmaceutical Co Ltd generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY5.3%-0.1%
TTM5.1%5Y7.3%-2.1%
5Y7.3%10Y5.2%+2.1%
1.1.3. Return on Equity

Shows how efficient Cisen Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.6% Return on Equity means Cisen Pharmaceutical Co Ltd generated ¥0.07 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 6.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM6.6%0.0%
TTM6.6%YOY6.6%0.0%
TTM6.6%5Y9.1%-2.6%
5Y9.1%10Y6.6%+2.5%

1.2. Operating Efficiency of Cisen Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cisen Pharmaceutical Co Ltd is operating .

  • Measures how much profit Cisen Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 7.2% means the company generated ¥0.07  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 7.2%. The company is operating less efficient.
  • The TTM is 7.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY5.7%+1.5%
TTM7.2%5Y9.4%-2.2%
5Y9.4%10Y7.9%+1.5%
1.2.2. Operating Ratio

Measures how efficient Cisen Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.35 means that the operating costs are ¥1.35 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 1.352. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.352. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.352TTM1.3520.000
TTM1.352YOY1.370-0.018
TTM1.3525Y1.321+0.031
5Y1.32110Y1.120+0.201

1.3. Liquidity of Cisen Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cisen Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.70 means the company has ¥3.70 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 3.701. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.701. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.701TTM3.7010.000
TTM3.701YOY3.400+0.301
TTM3.7015Y3.603+0.098
5Y3.60310Y2.341+1.262
1.3.2. Quick Ratio

Measures if Cisen Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.77 means the company can pay off ¥1.77 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 1.768. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.768. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.768TTM1.7680.000
TTM1.768YOY1.635+0.133
TTM1.7685Y1.809-0.041
5Y1.80910Y1.251+0.558

1.4. Solvency of Cisen Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cisen Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cisen Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Cisen Pharmaceutical Co Ltd assets are financed with 21.4% credit (debt) and the remaining percentage (100% - 21.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 0.214. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.214. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.2140.000
TTM0.214YOY0.206+0.009
TTM0.2145Y0.205+0.010
5Y0.20510Y0.241-0.036
1.4.2. Debt to Equity Ratio

Measures if Cisen Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.4% means that company has ¥0.27 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The MRQ is 0.274. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.274. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.274TTM0.2740.000
TTM0.274YOY0.259+0.015
TTM0.2745Y0.258+0.016
5Y0.25810Y0.322-0.064

2. Market Valuation of Cisen Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Cisen Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Cisen Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 16.32 means the investor is paying ¥16.32 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The EOD is 19.126. Based on the earnings, the company is fair priced.
  • The MRQ is 16.316. Based on the earnings, the company is fair priced.
  • The TTM is 16.316. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.126MRQ16.316+2.810
MRQ16.316TTM16.3160.000
TTM16.316YOY18.112-1.796
TTM16.3165Y15.409+0.906
5Y15.40910Y10.152+5.258
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The EOD is 30.004. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 25.596. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 25.596. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD30.004MRQ25.596+4.408
MRQ25.596TTM25.5960.000
TTM25.596YOY33.147-7.552
TTM25.5965Y40.285-14.690
5Y40.28510Y22.304+17.981
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cisen Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cisen Pharmaceutical Co Ltd:

  • The EOD is 1.250. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.066. Based on the equity, the company is underpriced. +1
  • The TTM is 1.066. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.250MRQ1.066+0.184
MRQ1.066TTM1.0660.000
TTM1.066YOY1.197-0.131
TTM1.0665Y1.375-0.308
5Y1.37510Y0.929+0.446
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cisen Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6630.6630%0.560+18%0.720-8%0.831-20%
Book Value Per Share--11.81511.8150%11.152+6%10.563+12%7.875+50%
Current Ratio--3.7013.7010%3.400+9%3.603+3%2.341+58%
Debt To Asset Ratio--0.2140.2140%0.206+4%0.205+5%0.241-11%
Debt To Equity Ratio--0.2740.2740%0.259+6%0.258+6%0.322-15%
Dividend Per Share--0.3080.3080%0.308+0%0.331-7%0.229+35%
Eps--0.7720.7720%0.737+5%0.945-18%0.662+17%
Free Cash Flow Per Share--0.4920.4920%0.403+22%0.476+3%0.403+22%
Free Cash Flow To Equity Per Share--0.4920.4920%-0.300+161%0.259+90%0.485+1%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max--8.849--------
Intrinsic Value_10Y_min---0.173--------
Intrinsic Value_1Y_max--0.566--------
Intrinsic Value_1Y_min--0.300--------
Intrinsic Value_3Y_max--1.944--------
Intrinsic Value_3Y_min--0.632--------
Intrinsic Value_5Y_max--3.618--------
Intrinsic Value_5Y_min--0.666--------
Market Cap6687486868.160+15%5711743800.0005711743800.0000%6051995550.000-6%6490954054.000-12%4144022673.000+38%
Net Profit Margin--0.0860.0860%0.088-3%0.110-22%0.077+12%
Operating Margin--0.0720.0720%0.057+26%0.094-24%0.079-10%
Operating Ratio--1.3521.3520%1.370-1%1.321+2%1.120+21%
Pb Ratio1.250+15%1.0661.0660%1.197-11%1.375-22%0.929+15%
Pe Ratio19.126+15%16.31616.3160%18.112-10%15.409+6%10.152+61%
Price Per Share14.770+15%12.60012.6000%13.350-6%14.318-12%9.141+38%
Price To Free Cash Flow Ratio30.004+15%25.59625.5960%33.147-23%40.285-36%22.304+15%
Price To Total Gains Ratio15.216+15%12.98112.9810%15.385-16%13.686-5%12.419+5%
Quick Ratio--1.7681.7680%1.635+8%1.809-2%1.251+41%
Return On Assets--0.0510.0510%0.053-2%0.073-29%0.052-1%
Return On Equity--0.0660.0660%0.066-1%0.091-28%0.066-1%
Total Gains Per Share--0.9710.9710%0.868+12%1.051-8%1.060-8%
Usd Book Value--740174778.251740174778.2510%698679979.206+6%661760118.189+12%493251975.386+50%
Usd Book Value Change Per Share--0.0920.0920%0.077+18%0.099-8%0.115-20%
Usd Book Value Per Share--1.6331.6330%1.541+6%1.460+12%1.088+50%
Usd Dividend Per Share--0.0430.0430%0.043+0%0.046-7%0.032+35%
Usd Eps--0.1070.1070%0.102+5%0.131-18%0.092+17%
Usd Free Cash Flow--30839780.36830839780.3680%25232521.921+22%29814834.126+3%25238608.066+22%
Usd Free Cash Flow Per Share--0.0680.0680%0.056+22%0.066+3%0.056+22%
Usd Free Cash Flow To Equity Per Share--0.0680.0680%-0.041+161%0.036+90%0.067+1%
Usd Market Cap924210685.180+15%789362993.160789362993.1600%836385785.010-6%897049850.263-12%572703933.409+38%
Usd Price Per Share2.041+15%1.7411.7410%1.845-6%1.979-12%1.263+38%
Usd Profit--48380051.59748380051.5970%46179035.646+5%59180793.368-18%38077311.585+27%
Usd Revenue--561933423.592561933423.5920%522754302.169+7%537423964.627+5%442595908.226+27%
Usd Total Gains Per Share--0.1340.1340%0.120+12%0.145-8%0.146-8%
 EOD+4 -4MRQTTM+0 -0YOY+26 -95Y+13 -2210Y+24 -12

3.2. Fundamental Score

Let's check the fundamental score of Cisen Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.126
Price to Book Ratio (EOD)Between0-11.250
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.072
Quick Ratio (MRQ)Greater than11.768
Current Ratio (MRQ)Greater than13.701
Debt to Asset Ratio (MRQ)Less than10.214
Debt to Equity Ratio (MRQ)Less than10.274
Return on Equity (MRQ)Greater than0.150.066
Return on Assets (MRQ)Greater than0.050.051
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Cisen Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.562
Ma 20Greater thanMa 5014.651
Ma 50Greater thanMa 10014.166
Ma 100Greater thanMa 20014.487
OpenGreater thanClose14.970
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Minority Interest  1,0062131,219-224995-750245-2,558-2,313



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,815,073
Total Liabilities1,459,250
Total Stockholder Equity5,332,181
 As reported
Total Liabilities 1,459,250
Total Stockholder Equity+ 5,332,181
Total Assets = 6,815,073

Assets

Total Assets6,815,073
Total Current Assets4,744,960
Long-term Assets2,070,113
Total Current Assets
Cash And Cash Equivalents 997,948
Short-term Investments 1,549,710
Net Receivables 716,164
Inventory 580,434
Other Current Assets 99,631
Total Current Assets  (as reported)4,744,960
Total Current Assets  (calculated)3,943,886
+/- 801,074
Long-term Assets
Property Plant Equipment 1,488,742
Intangible Assets 213,032
Long-term Assets Other 247,864
Long-term Assets  (as reported)2,070,113
Long-term Assets  (calculated)1,949,638
+/- 120,476

Liabilities & Shareholders' Equity

Total Current Liabilities1,281,921
Long-term Liabilities177,329
Total Stockholder Equity5,332,181
Total Current Liabilities
Short Long Term Debt 57,794
Accounts payable 459,711
Other Current Liabilities 504,634
Total Current Liabilities  (as reported)1,281,921
Total Current Liabilities  (calculated)1,022,139
+/- 259,782
Long-term Liabilities
Long term Debt 100,000
Capital Lease Obligations Min Short Term Debt512
Deferred Long Term Liability 3,864
Long-term Liabilities  (as reported)177,329
Long-term Liabilities  (calculated)104,376
+/- 72,953
Total Stockholder Equity
Retained Earnings 2,761,952
Total Stockholder Equity (as reported)5,332,181
Total Stockholder Equity (calculated)2,761,952
+/- 2,570,229
Other
Capital Stock453,313
Common Stock Shares Outstanding 453,313
Net Invested Capital 5,489,975
Net Tangible Assets 5,119,150
Net Working Capital 3,463,039
Property Plant and Equipment Gross 1,488,742



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
1,574,503
2,034,714
2,362,904
2,693,564
3,034,022
3,280,771
4,741,888
5,248,390
5,533,753
6,165,710
6,363,715
6,815,073
6,815,0736,363,7156,165,7105,533,7535,248,3904,741,8883,280,7713,034,0222,693,5642,362,9042,034,7141,574,503
   > Total Current Assets 
0
0
0
0
0
1,497,106
3,085,256
3,595,103
3,782,462
3,950,230
4,144,561
4,744,960
4,744,9604,144,5613,950,2303,782,4623,595,1033,085,2561,497,10600000
       Cash And Cash Equivalents 
143,306
177,914
17,698
18,609
208,808
429,902
1,403,403
345,761
382,417
661,417
938,978
997,948
997,948938,978661,417382,417345,7611,403,403429,902208,80818,60917,698177,914143,306
       Short-term Investments 
0
0
0
0
60,000
120,000
20,000
14,331
1,976,592
1,875,243
1,484,641
1,549,710
1,549,7101,484,6411,875,2431,976,59214,33120,000120,00060,0000000
       Net Receivables 
276,314
331,177
368,055
398,976
414,047
593,255
631,049
721,021
737,343
498,902
508,207
716,164
716,164508,207498,902737,343721,021631,049593,255414,047398,976368,055331,177276,314
       Other Current Assets 
64,043
81,532
92,811
35,196
34,371
31,644
27,485
1,852,166
81,343
93,844
66,446
99,631
99,63166,44693,84481,3431,852,16627,48531,64434,37135,19692,81181,53264,043
   > Long-term Assets 
0
0
0
0
0
1,783,664
1,656,633
1,653,287
1,751,291
2,215,481
2,219,154
2,070,113
2,070,1132,219,1542,215,4811,751,2911,653,2871,656,6331,783,66400000
       Property Plant Equipment 
647,805
845,078
1,215,637
1,531,321
1,513,262
1,449,838
1,305,111
1,286,274
1,344,088
1,636,768
1,591,087
1,488,742
1,488,7421,591,0871,636,7681,344,0881,286,2741,305,1111,449,8381,513,2621,531,3211,215,637845,078647,805
       Intangible Assets 
85,380
83,719
170,768
189,642
188,407
188,029
189,137
188,981
208,016
207,919
210,820
213,032
213,032210,820207,919208,016188,981189,137188,029188,407189,642170,76883,71985,380
       Long-term Assets Other 
0
0
0
0
0
35,569
36,121
41,553
74,569
248,819
302,541
247,864
247,864302,541248,81974,56941,55336,12135,56900000
> Total Liabilities 
230,022
450,063
636,480
792,435
935,327
982,261
1,017,593
1,093,392
959,974
1,363,765
1,308,144
1,459,250
1,459,2501,308,1441,363,765959,9741,093,3921,017,593982,261935,327792,435636,480450,063230,022
   > Total Current Liabilities 
226,022
435,633
558,814
703,073
851,022
735,537
918,882
1,007,986
885,539
1,284,346
1,218,940
1,281,921
1,281,9211,218,9401,284,346885,5391,007,986918,882735,537851,022703,073558,814435,633226,022
       Short-term Debt 
0
0
0
0
0
90,000
0
0
0
0
0
0
00000090,00000000
       Short Long Term Debt 
0
0
0
0
0
90,000
0
0
100,000
330,000
130,000
57,794
57,794130,000330,000100,0000090,00000000
       Accounts payable 
116,987
216,818
335,929
398,489
513,482
436,000
534,889
491,689
390,599
502,132
434,969
459,711
459,711434,969502,132390,599491,689534,889436,000513,482398,489335,929216,818116,987
       Other Current Liabilities 
109,036
118,815
122,885
154,584
187,541
128,297
174,769
203,637
191,423
232,471
436,729
504,634
504,634436,729232,471191,423203,637174,769128,297187,541154,584122,885118,815109,036
   > Long-term Liabilities 
0
0
0
0
0
246,723
98,711
85,406
74,435
79,419
89,203
177,329
177,32989,20379,41974,43585,40698,711246,72300000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-90,000
0
0
0
1,041
10,909
512
51210,9091,041000-90,00000000
       Long-term Liabilities Other 
0
0
0
0
0
160,000
0
0
0
0
0
0
000000160,00000000
       Deferred Long Term Liability 
0
0
0
0
841
621
402
183
0
0
2,047
3,864
3,8642,047001834026218410000
> Total Stockholder Equity
1,344,481
1,584,651
1,724,688
1,898,905
2,097,704
2,295,469
3,722,799
4,153,992
4,572,559
4,800,950
5,054,821
5,332,181
5,332,1815,054,8214,800,9504,572,5594,153,9923,722,7992,295,4692,097,7041,898,9051,724,6881,584,6511,344,481
   Common Stock
321,230
321,230
353,353
353,353
353,353
353,353
453,353
453,353
453,353
453,353
453,333
0
0453,333453,353453,353453,353453,353353,353353,353353,353353,353321,230321,230
   Retained Earnings 
119,801
359,971
500,009
674,225
873,024
1,070,790
1,387,835
1,818,844
2,237,599
2,556,196
2,774,406
2,761,952
2,761,9522,774,4062,556,1962,237,5991,818,8441,387,8351,070,790873,024674,225500,009359,971119,801
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
-63
122
-66
-2,121
-3,068
0
0-3,068-2,121-66122-63000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,364,111
Cost of Revenue-1,901,971
Gross Profit2,462,1402,462,140
 
Operating Income (+$)
Gross Profit2,462,140
Operating Expense-3,900,021
Operating Income464,090-1,437,881
 
Operating Expense (+$)
Research Development348,710
Selling General Administrative1,456,706
Selling And Marketing Expenses-
Operating Expense3,900,0211,805,416
 
Net Interest Income (+$)
Interest Income31,772
Interest Expense-6,066
Other Finance Cost-5,356
Net Interest Income31,063
 
Pretax Income (+$)
Operating Income464,090
Net Interest Income31,063
Other Non-Operating Income Expenses-
Income Before Tax (EBT)486,595464,090
EBIT - interestExpense = -6,066
448,190
454,255
Interest Expense6,066
Earnings Before Interest and Taxes (EBIT)-492,661
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax486,595
Tax Provision-25,542
Net Income From Continuing Ops461,053461,053
Net Income448,190
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--31,063
 

Technical Analysis of Cisen Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cisen Pharmaceutical Co Ltd. The general trend of Cisen Pharmaceutical Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cisen Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cisen Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 16.41 < 16.55.

The bearish price targets are: 14.88 > 14.77 > 13.80.

Tweet this
Cisen Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cisen Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cisen Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cisen Pharmaceutical Co Ltd. The current macd is 0.19257857.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cisen Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cisen Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cisen Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cisen Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartCisen Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cisen Pharmaceutical Co Ltd. The current adx is 14.61.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cisen Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cisen Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cisen Pharmaceutical Co Ltd. The current sar is 15.42.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cisen Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cisen Pharmaceutical Co Ltd. The current rsi is 52.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Cisen Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartCisen Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cisen Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cisen Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cisen Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartCisen Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cisen Pharmaceutical Co Ltd. The current cci is 46.08.

Cisen Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartCisen Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cisen Pharmaceutical Co Ltd. The current cmo is 1.26605842.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cisen Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartCisen Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cisen Pharmaceutical Co Ltd. The current willr is -41.56626506.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cisen Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cisen Pharmaceutical Co Ltd Daily Williams %R ChartCisen Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cisen Pharmaceutical Co Ltd.

Cisen Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cisen Pharmaceutical Co Ltd. The current atr is 0.42396655.

Cisen Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartCisen Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cisen Pharmaceutical Co Ltd. The current obv is 157,977,829.

Cisen Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartCisen Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cisen Pharmaceutical Co Ltd. The current mfi is 66.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cisen Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartCisen Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cisen Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Cisen Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cisen Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.562
Ma 20Greater thanMa 5014.651
Ma 50Greater thanMa 10014.166
Ma 100Greater thanMa 20014.487
OpenGreater thanClose14.970
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cisen Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Cisen Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cisen Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cisen Pharmaceutical Co Ltd

I send you an email if I find something interesting about Cisen Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Cisen Pharmaceutical Co Ltd.

Receive notifications about Cisen Pharmaceutical Co Ltd in your mailbox!